| 0 (0%) | 09-24 03:07 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 54.83 | 1-year : | 64.05 |
| Resists | First : | 46.95 | Second : | 54.83 |
| Pivot price | 7.03 |
|||
| Supports | First : | 18.14 | Second : | 0.34 |
| MAs | MA(5) : | 20.23 |
MA(20) : | 5.37 |
| MA(100) : | 1.36 |
MA(250) : | 0.69 |
|
| MACD | MACD : | 5.9 |
Signal : | 2.4 |
| %K %D | K(14,3) : | 70.9 |
D(3) : | 63.7 |
| RSI | RSI(14): 68.7 |
|||
| 52-week | High : | 46.95 | Low : | 0.15 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VYNE ] has closed below upper band by 11.0%. Bollinger Bands are 3449.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 28.75 - 28.87 | 28.87 - 28.96 |
| Low: | 23.11 - 23.22 | 23.22 - 23.33 |
| Close: | 28.32 - 28.55 | 28.55 - 28.74 |
Mon, 21 Sep 2026
VYNE stock trades quietly as investors look to recent dermatology trial data - AD HOC NEWS
Mon, 21 Sep 2026
Vyne Sells Medical Business to Focus on Dental - DrBicuspid.com
Thu, 17 Sep 2026
Vyne Sharpens Focus on Dental With Sale of Vyne Medical to MRO - GlobeNewswire
Wed, 16 Sep 2026
M&A: MRO Acquires Vyne Medical to Expand Intelligent Healthcare Intake Automation - HIT Consultant
Wed, 16 Sep 2026
MRO buys Vyne Medical to capture clinical data trapped in faxes and calls - Dealroom
Wed, 16 Sep 2026
MRO Expands Enterprise Clinical Data Management Platform with Acquisition of Vyne Medical - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 613690 (%) |
| Held by Institutions | 17.9 (%) |
| Shares Short | 2 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.434e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 437.2 % |
| Return on Equity (ttm) | -37.1 % |
| Qtrly Rev. Growth | 454000 % |
| Gross Profit (p.s.) | -28.56 |
| Sales Per Share | -31.43 |
| EBITDA (p.s.) | 225871 |
| Qtrly Earnings Growth | -27.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.91 |
| Price to Cash Flow | 1.55 |
| Dividend | 0 |
| Forward Dividend | 3680 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2000-12-20 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|